PT

Dados B3 › BPHA3 × FLRY3

BPHA3 × FLRY3

BPHA3

MASSA FALIDA DA BRASIL PHARMA SA
Saúde

15 restated figures

FLRY3

FLEURY SA
Saúde

14 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicatorBPHA3FLRY3year
ROE-149.5%14.3%2016
ROIC-348.5%!17.6%2017
ROA966.4%!8.9%2018
Gross margin98.3%!30.3%2018
EBIT margin-302.4%!18.9%2018
Net margin10,996.5%!12.4%2018
Net debt/EBITDA19.79x1.60x2013
Current ratio0.06x!2.30x2018
Revenue growth (1y)-17.5%!11.8%2018
Revenue growth (5y CAGR)-68.9%!10.0%2018
Piotroski F-Score5/9!5/92018

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicatorBPHA3FLRY3year
P/E0.15x14.26x2018 × 2025
P/B—1.75x2018 × 2025
EV/EBITDA—5.58x2018 × 2025
FCF yield-55.2%18.6%2018 × 2025

BPHA3 · FLRY3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:29 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:29 UTC. If this does not match /saude, you are reading a cached copy.